Cristina Dominguez

Cristina Dominguez

Auto-generated profile, based on publicly available information

Cristina Dominguez

Department of Urology, Hospital Universitario Fundación Santa Fe de Bogotá, Bogotá, Colombia

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2018 in International braz j urol
Verified
Journal Article
Open access
PDF file
CDCristina Dominguez
Cristina Dominguez
MPMauricio Plata
Mauricio Plata
JCJuan Guillermo Cataño
Juan Guillermo Cataño
MPMauricio Palau
Mauricio Palau
DADiego Aguirre
Diego Aguirre
CMCamilo Medina
Camilo Medina
Keywords: Prostatic Neoplasms; Magnetic Resonance Imaging; Prostatectomy

25 September 2014 in JMIR mHealth and uHealth
Verified
Journal Article
Open access
CLCatalina Lopez
Catalina Lopez
DRDaniel Camilo Ramirez
Daniel Camilo Ramirez
JVJose Ignacio Valenzuela
Jose Ignacio Valenzuela
AAArturo Arguello
Arturo Arguello
JSJuan Pablo Saenz
Juan Pablo Saenz
CDCristina Dominguez
Cristina Dominguez
Mobile and tablet apps, ubiquitous and pervasive computing, wearable computing and domotics for health.

1 November 2015 in Journal of Endourology
Verified
Journal Article
Closed access
MPMauricio Plata
Mauricio Plata
CTCarlos G. Trujillo
Carlos G. Trujillo
CDCristina Domínguez
Cristina Domínguez
JCJuan Ignacio Caicedo
Juan Ignacio Caicedo
GCGabriel Leonardo Carreño
Gabriel Leonardo Carreño
JCJuan G. Cataño
Juan G. Cataño
To determine safety, efficacy, and improvement in patient's quality of life (QoL) with 180-W green light laser prostate photovaporization in medium-term follow-up. Observational descriptive analysis. All the patients who were treated with photoselective vaporization with potassium titanyl phosphate crystal 180-W green laser between January 2012 and February 2014 were included. The primary outcome was the change of the International Prostate Symptom Score (IPSS). A descriptive analysis was conducted. Statistic inference was made using nonparametric measurements according to the findings. The Wilcoxon signed-rank test was applied to paired data. Finally, survival curves were used to determine the effectiveness. Two hundred one subjects were included. The mean follow-up was 13.1 months (2-28). Prostate volume was 75.46 ml (30-240). Mean surgical time was 73.29±29.74 minutes, laser time was 44.27±21.03 minutes, and the mean energy used was 271.5±140.1 kJ. Postoperative indwelling catheter time was 15.81±8.87 hours. IPSS decreased 12.79 points, from 19.13±7.79 to 6.34±5.91 (p=0.0001). QoL question of the IPSS shows improvement from 4.16 to 1.27 (p=0.00001). In a maximum follow-up period of 28 months, 85.2% of patients showed an improvement of four points in IPSS. Visual scale of improvement perception showed an increase from 36.49 to 89.84 (p=0.0001). No major complications were reported. Prostate photoselective vaporization with a 180-W green light laser is a safe and effective treatment option for patients with lower urinary symptoms secondary to benign prostate enlargement.

23 February 2018 in Acta Chirurgica Belgica
Verified
Journal Article
Closed access
CTCarlos Gustavo Trujillo
Carlos Gustavo Trujillo
CDCristina Domínguez
Cristina Domínguez
DRDaniela Robledo
Daniela Robledo
JCJuan Ignacio Caicedo
Juan Ignacio Caicedo
ABAlejandra Bravo-Balado
Alejandra Bravo-Balado
MPMauricio Plata
Mauricio Plata
Background: Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS-HIPEC) is associated with significant manipulation of the urinary tract (UT). We aim to describe the urological events and their management in patients who underwent CRS-HIPEC. Methods: Clinical records of patients who underwent treatment between 2007 and 2015 were reviewed. Urological events and their multidisciplinary management were analyzed. Descriptive statistics were calculated. Results: A total of 103 patients were included. Mean age was 51 years (SD ± 11.8). Mean peritoneal cancer index (PCI) was 20.4 (SD ± 10.1). Primary tumors included appendicular (64%), gynecological (16%), colorectal (10%), and peritoneal mesotheliomas (9%). Ninety-three percent of patients had bilateral ureteral catheters inserted prior to surgery, without complications. Intraoperative UT injuries occurred in 7% of patients. In 5% of patients, tumor invasion of the bladder was evident at surgery and partial resection and primary repair of the bladder wall was performed. Urological complications included urinary tract infection (UTI) (21%) acute post-renal failure (4%), urinary fistulae (4%), and acute urinary retention (AUR) (1%). Conclusions: In our study, intraoperative UT events and postoperative complications, although not neglectable, were infrequent. Due to the high complexity of these cases, a multidisciplinary approach is mandatory. However, randomized clinical trials are necessary to clarify current data on the need and efficacy of prophylactic ureteral catheterization in patients undergoing CRS-HIPEC.

1 June 2015 in Pediatric Urology Case Reports
Verified
Journal Article
Open access
PDF file
JPJaime Pérez
Jaime Pérez
CDCristina Domínguez
Cristina Domínguez
Scrotal approach for the correction of an abdominoscrotal hydrocele: Medium term follow-up

8 April 2017 in Radiography
Verified
Journal Article
Closed access
PDF file
AVA. Vásquez
A. Vásquez
CDC. Domínguez
C. Domínguez
CPC.F. Perdomo
C.F. Perdomo